News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
70,792 Results
Type
Article (1942)
Company Profile (3)
Press Release (68847)
Section
Business (21542)
Career Advice (9)
Deals (4566)
Drug Delivery (1)
Drug Development (8174)
FDA (1810)
Job Trends (803)
News (37141)
Policy (3586)
Tag
Academia (93)
Allergies (6)
Alliances (8186)
ALS (7)
Alzheimer's disease (131)
Antibody-drug conjugate (ADC) (18)
Approvals (1845)
Artificial intelligence (16)
Automation (1)
Bankruptcy (8)
Best Places to Work (586)
Biosimilars (34)
Biotechnology (5)
Bladder cancer (15)
Brain cancer (2)
Breast cancer (29)
Cancer (292)
Cardiovascular disease (6)
Career advice (9)
CAR-T (6)
Cell therapy (32)
Clinical research (7140)
Collaboration (130)
Compensation (13)
Complete response letters (2)
COVID-19 (192)
C-suite (25)
Cystic fibrosis (4)
Data (291)
Depression (4)
Diabetes (21)
Diagnostics (604)
Digital health (1)
Drug discovery (16)
Duchenne muscular dystrophy (17)
Earnings (7744)
Events (7124)
Executive appointments (53)
FDA (2005)
Fibrodysplasia Ossificans Progressiva (1)
Funding (81)
Gene editing (3)
Gene therapy (21)
GLP-1 (54)
Government (238)
Grass and pollen (1)
Guidances (17)
Healthcare (1079)
HIV (1)
Huntington's disease (1)
IgA nephropathy (8)
Immunology and inflammation (2)
Indications (5)
Infectious disease (199)
Inflammatory bowel disease (18)
Influenza (7)
Intellectual property (20)
IPO (1642)
Job creations (243)
Job search strategy (9)
Layoffs (6)
Legal (956)
Liver cancer (17)
Lung cancer (51)
Lymphoma (19)
Manufacturing (37)
MASH (8)
Medical device (1131)
Medtech (1132)
Mergers & acquisitions (3038)
Metabolic disorders (51)
Multiple sclerosis (10)
NASH (1)
Neurodegenerative disease (7)
Neuroscience (193)
NextGen: Class of 2025 (221)
Non-profit (62)
Obesity (21)
Opinion (2)
Ovarian cancer (14)
Pain (5)
Pancreatic cancer (9)
Parkinson's disease (21)
Partnered (2)
Patents (29)
Patient recruitment (13)
People (5020)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase I (1938)
Phase II (3005)
Phase III (2696)
Pipeline (179)
Policy (1)
Postmarket research (242)
Preclinical (676)
Press Release (2)
Prostate cancer (9)
Radiopharmaceuticals (22)
Rare diseases (34)
Real estate (601)
Regulatory (2657)
Reports (6)
Research institute (93)
RNA editing (1)
Schizophrenia (10)
Series A (18)
Series B (11)
Service/supplier (1)
Sickle cell disease (2)
Spinal muscular atrophy (4)
Sponsored (1)
Startups (423)
Stomach cancer (1)
Supply chain (8)
Vaccines (26)
Venture capital (2)
Weight loss (4)
Women's health (1)
Date
Today (5)
Last 7 days (22)
Last 30 days (167)
Last 365 days (2721)
2025 (1468)
2024 (3259)
2023 (3822)
2022 (7042)
2021 (6414)
2020 (5934)
2019 (3888)
2018 (3014)
2017 (3569)
2016 (3185)
2015 (4046)
2014 (3025)
2013 (2604)
2012 (2784)
2011 (2904)
2010 (2663)
Location
Africa (85)
Alabama (3)
Arizona (9)
Asia (21613)
Australia (2437)
California (430)
Canada (264)
China (224)
Colorado (4)
Connecticut (18)
Delaware (4)
Europe (12631)
Florida (39)
Georgia (9)
Illinois (22)
India (14)
Indiana (6)
Japan (119)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (83)
Massachusetts (298)
Michigan (3)
Minnesota (29)
Missouri (3)
Nebraska (1)
Nevada (1)
New Jersey (249)
New York (176)
North Carolina (66)
Northern California (162)
Ohio (3)
Oregon (1)
Pennsylvania (71)
South America (107)
Southern California (201)
Tennessee (1)
Texas (40)
United States (1621)
Utah (13)
Virginia (32)
Washington D.C. (3)
Washington State (20)
Wisconsin (6)
70,792 Results for "cipla ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA
Exelixis, Inc. (Nasdaq: EXEL) today announced that it has entered into a Settlement and License Agreement (Agreement) with Cipla Ltd. and Cipla USA, Inc. (collectively Cipla).
May 20, 2024
·
3 min read
Press Releases
Cipla and Formosa sign multi-regional licensing deal for Clobetasol Suspension
March 18, 2025
·
4 min read
Press Releases
Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK
Antev Shareholders to Receive Aggregate ~17% Equity Stake in Medicus plus US$65 Million in Contingent Payments
June 30, 2025
·
10 min read
Press Releases
Faron Pharmaceuticals Ltd: Director/PCA Dealing
July 1, 2025
·
3 min read
Press Releases
Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer
June 23, 2025
·
1 min read
Business
Pulmatrix Announces Stopping the PUR1900 Phase 2B Study Patient Enrollment and Closing the Study, in Agreement With Partner Cipla, to Preserve Cash and Facilitate Pursuit of Strategic Alternatives
Pulmatrix today announced that it has entered into a further amendment to its agreement with Cipla for the development of PUR1900 in the treatment of Allergic Bronchopulmonary Aspergillosis (ABPA).
January 8, 2024
·
6 min read
Press Releases
Medicus Pharma Ltd. to Present at 2025 Bio International Convention
Company Executive Chairman & CEO to Provide Corporate Updates on June 17th 2025
June 12, 2025
·
6 min read
Press Releases
Restore Medical LTD secures $23M to Advance Breakthrough Medical Device for Heart Failure Therapy
July 8, 2025
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Grant of Options
May 15, 2025
·
5 min read
Press Releases
Medicus Pharma Ltd. Announces Submission of Type C Meeting Request to the Food and Drug Administration (FDA)
July 8, 2025
·
8 min read
1 of 7,080
Next
